AAAAAA

   
Results: 1-11 |
Results: 11
Coping strategies and health care-seeking behavior in a US national sampleof adults with symptoms suggestive of overactive bladder
Authors: Ricci, JA Baggish, JS Hunt, TL Stewart, WF Wein, A Herzog, AR Diokno, AC
Citation: Ja. Ricci et al., Coping strategies and health care-seeking behavior in a US national sampleof adults with symptoms suggestive of overactive bladder, CLIN THER, 23(8), 2001, pp. 1245-1259
Health-related quality of life among adults with symptoms of overactive bladder: Results from a US community-based survey
Authors: Liberman, JN Hunt, TL Stewart, WF Wein, A Zhou, ZY Herzog, AR Lipton, RB Diokno, AC
Citation: Jn. Liberman et al., Health-related quality of life among adults with symptoms of overactive bladder: Results from a US community-based survey, UROLOGY, 57(6), 2001, pp. 1044-1050
Celecoxib, a specific COX-2 inhibitor, has no significant effect on MTX pharmacokinetics or renal clearance in patients with RA (vol 26, pg 2539, 1999)
Authors: Karim, A Tolbert, DS Hunt, TL Hubbard, RC Harper, KM Geis, GS
Citation: A. Karim et al., Celecoxib, a specific COX-2 inhibitor, has no significant effect on MTX pharmacokinetics or renal clearance in patients with RA (vol 26, pg 2539, 1999), J RHEUMATOL, 27(2), 2000, pp. 557-557
Absence of pharmacokinetic interaction between orally co-administered naproxen sodium and diphenhydramine hydrochloride
Authors: Toothaker, RD Barker, SH Gillen, MV Helsinger, SA Kindberg, CG Hunt, TL Powell, JH
Citation: Rd. Toothaker et al., Absence of pharmacokinetic interaction between orally co-administered naproxen sodium and diphenhydramine hydrochloride, BIOPHARM DR, 21(6), 2000, pp. 229-233
The effect of rofecoxib on the pharmacodynamics and pharmacokinetics of warfarin
Authors: Schwartz, JI Bugianesi, KJ Ebel, DL De Smet, M Haesen, R Larson, PJ Ko, A Verbesselt, R Hunt, TL Lins, R Lens, S Porras, AG Dieck, J Keymeulen, B Gertz, BJ
Citation: Ji. Schwartz et al., The effect of rofecoxib on the pharmacodynamics and pharmacokinetics of warfarin, CLIN PHARM, 68(6), 2000, pp. 626-636
Celecoxib, a specific COX-2 inhibitor, has no significant effect on methotrexate pharmacokinetics in patients with rheumatoid arthritis
Authors: Karim, A Tolbert, DS Hunt, TL Hubbard, RC Harper, KM Geis, GS
Citation: A. Karim et al., Celecoxib, a specific COX-2 inhibitor, has no significant effect on methotrexate pharmacokinetics in patients with rheumatoid arthritis, J RHEUMATOL, 26(12), 1999, pp. 2539-2543
Effects of food on the pharmacokinetics of sparfloxacin
Authors: Johnson, RD Dorr, MB Hunt, TL Jensen, BK Talbot, GH
Citation: Rd. Johnson et al., Effects of food on the pharmacokinetics of sparfloxacin, CLIN THER, 21(6), 1999, pp. 982-991
Pharmacokinetic interaction of sparfloxacin and digoxin
Authors: Johnson, RD Dorr, MB Hunt, TL Conway, S Talbot, GH
Citation: Rd. Johnson et al., Pharmacokinetic interaction of sparfloxacin and digoxin, CLIN THER, 21(2), 1999, pp. 368-379
The unruly Queen. The life of Queen Caroline
Authors: Hunt, TL
Citation: Tl. Hunt, The unruly Queen. The life of Queen Caroline, ALBION, 31(1), 1999, pp. 127-128
Pharmacokinetics, safety, and tolerability of single intravenous infusionsof an adenosine agonist, AMP 579, in healthy male volunteers
Authors: Zannikos, PN Baybutt, RI Boutouyrie, BX Shah, B Hunt, TL Jensen, BK
Citation: Pn. Zannikos et al., Pharmacokinetics, safety, and tolerability of single intravenous infusionsof an adenosine agonist, AMP 579, in healthy male volunteers, J CLIN PHAR, 39(10), 1999, pp. 1044-1052
The unruly queen: The life of Queen Caroline
Authors: Hunt, TL
Citation: Tl. Hunt, The unruly queen: The life of Queen Caroline, ALBION, 30(4), 1998, pp. 706-708
Risultati: 1-11 |